234 related articles for article (PubMed ID: 28824737)
1. Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?
Polivka J; Kralickova M; Polivka J; Kaiser C; Kuhn W; Golubnitschaja O
EPMA J; 2017 Jun; 8(2):119-127. PubMed ID: 28824737
[TBL] [Abstract][Full Text] [Related]
2. Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics.
Girotra S; Yeghiazaryan K; Golubnitschaja O
Per Med; 2016 Sep; 13(5):469-484. PubMed ID: 29767597
[TBL] [Abstract][Full Text] [Related]
3. Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification.
Fröhlich H; Patjoshi S; Yeghiazaryan K; Kehrer C; Kuhn W; Golubnitschaja O
EPMA J; 2018 Jun; 9(2):175-186. PubMed ID: 29896316
[TBL] [Abstract][Full Text] [Related]
4. "Pre-metastatic niches" in breast cancer: are they created by or prior to the tumour onset? "Flammer Syndrome" relevance to address the question.
Bubnov R; Polivka J; Zubor P; Konieczka K; Golubnitschaja O
EPMA J; 2017 Jun; 8(2):141-157. PubMed ID: 28725292
[TBL] [Abstract][Full Text] [Related]
5. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach.
Golubnitschaja O; Potuznik P; Polivka J; Pesta M; Kaverina O; Pieper CC; Kropp M; Thumann G; Erb C; Karabatsiakis A; Stetkarova I; Polivka J; Costigliola V
EPMA J; 2022 Dec; 13(4):535-545. PubMed ID: 36415625
[TBL] [Abstract][Full Text] [Related]
6. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions.
Kucera R; Pecen L; Topolcan O; Dahal AR; Costigliola V; Giordano FA; Golubnitschaja O
EPMA J; 2020 Sep; 11(3):399-418. PubMed ID: 32843909
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach.
Golubnitschaja O; Polivka J; Yeghiazaryan K; Berliner L
EPMA J; 2018 Sep; 9(3):271-285. PubMed ID: 30174763
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal breast cancer: European challenge and innovative concepts.
Smokovski I; Risteski M; Polivka J; Zubor P; Konieczka K; Costigliola V; Golubnitschaja O
EPMA J; 2017 Jun; 8(2):159-169. PubMed ID: 28824739
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine.
Golubnitschaja O; Filep N; Yeghiazaryan K; Blom HJ; Hofmann-Apitius M; Kuhn W
Amino Acids; 2018 Apr; 50(3-4):383-395. PubMed ID: 29249020
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers.
Bryan S; Witzel I; Borgmann K; Oliveira-Ferrer L
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439289
[TBL] [Abstract][Full Text] [Related]
14. External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis.
Genre L; Roché H; Varela L; Kanoun D; Ouali M; Filleron T; Dalenc F
Eur J Cancer; 2017 Feb; 72():200-209. PubMed ID: 28042991
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
[TBL] [Abstract][Full Text] [Related]
16. Development and external validation of a prediction model for brain metastases in patients with metastatic breast cancer.
Wu Q; Sun MS; Liu YH; Ye JM; Xu L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12333-12353. PubMed ID: 37432458
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach?
Zubor P; Gondova A; Polivka J; Kasajova P; Konieczka K; Danko J; Golubnitschaja O
EPMA J; 2017 Jun; 8(2):129-140. PubMed ID: 28824738
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer under age 40: a different approach.
Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F
Curr Treat Options Oncol; 2015 Apr; 16(4):16. PubMed ID: 25796377
[TBL] [Abstract][Full Text] [Related]
19. Brain metastases from breast cancer.
Santos J; Arantes J; Carneiro E; Ferreira D; Silva SM; Palma de Sousa S; Arantes M
Clin Neurol Neurosurg; 2020 Oct; 197():106150. PubMed ID: 32920499
[TBL] [Abstract][Full Text] [Related]
20. A novel orthotopic model of breast cancer metastasis to bone.
Lelekakis M; Moseley JM; Martin TJ; Hards D; Williams E; Ho P; Lowen D; Javni J; Miller FR; Slavin J; Anderson RL
Clin Exp Metastasis; 1999 Mar; 17(2):163-70. PubMed ID: 10411109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
